Its official name is BA.3.2, but it’s earned the nickname "cicada" because, analogous to the insect’s pattern, it first appeared back in 2024, went dormant for a while, and resurfaced in the U.S. late ...
Like the insect, the Cicada COVID-19 variant has shown a pattern of disappearing and reappearing months later.
A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...
The COVID-19 variant BA.3.2, nicknamed "Cicada," has been detected in at least 23 countries and half the states in the U.S.
The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study. First head-to-head, double-blind, randomized phase 4 study powered to ...
About half of patients are age 10 to 29, and the Japan Pediatric Society is calling on people to get vaccinated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results